Laureate Education Class A LAUR 深 沪
等待开盘 11-06 09:30:00 美东时间
30.74
+1.080
+3.64%
华盛通- 最 高30.82
- 今 开29.85
- 成交量 114.80万股
- 最 低 29.79
- 昨 收 29.66
- 总市值 45.80亿
- 52周最高 32.415
- 市盈率 静 15.96
- 换手率 0.77%
- 52周最低 17.82
- 委 比 -4.31%
- 总股本 1.49亿
- 历史最高 32.415
- 量 比 0.66
- 振 幅 3.47%
- 历史最低 -2.50
- 每 手 1
- 风险率 4.04%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 高盛上调英伟达目标价升至240美元； Loop Capital上调英伟达目标价升至350美元！
今日重点评级关注：花旗：维持Caribou Biosciences"买入"评级，目标价从5美元升至8美元；HC Wainwright & Co.：上调MoonLake Immunotherapeutics - Class A Ordinary Shares评级至"买入"，目标价30美元
11-04 10:31
Laureate Education Boosts Stock Repurchase by $150 Million
The latest announcement is out from Laureate Education ( ($LAUR) ). On October ...
10-30 19:27
Laureate Education Raises FY2025 Sales Guidance from $1.615B-$1.630B to $1.681B-$1.686B vs $1.636B Est
Laureate Education (NASDAQ:LAUR) raises FY2025 sales outlook from $1.615 billion-$1.630 billion to $1.681 billion-$1.686 billion vs $1.636 billion estimate.
10-30 19:16
Laureate Education Q3 EPS $0.23 Misses $0.33 Estimate, Sales $400.200M Beat $384.280M Estimate
Laureate Education (NASDAQ:LAUR) reported quarterly earnings of $0.23 per share which missed the analyst consensus estimate of $0.33 by 30.3 percent. This is a 58.93 percent decrease over earnings of $0.56 per share from
10-30 19:15
Earnings Scheduled For October 30, 2025
Companies Reporting Before The Bell • Altria Group (NYSE:MO) is projected to re...
10-30 19:12
If You Invested $1000 In Laureate Education Stock 5 Years Ago, You Would Have This Much Today
Laureate Education (NASDAQ:LAUR) has outperformed the market over the past 5 ye...
10-30 00:45
美股大行评级 | 潜在涨幅344.44%！Rani Therapeutics获Maxim Group升目标价至10美元，维持"买入"评级
今日重点评级关注：Maxim Group：维持Rani Therapeutics Hldgs"买入"评级，目标价从5美元升至10美元；韦德布什：维持Corbus Pharmaceuticals"跑赢大市"评级，目标价从31美元升至38美元
10-21 18:13
Personalis Announces Phase 3 LAURA Trial Data With AstraZeneca Showing NeXT Personal MRD Test Effectively Assesses Post-CRT Response In EGFRm Stage III NSCLC
Personalis, Inc. (NASDAQ:PSNL), a leader in advanced genomics for precision oncology, announced new data from an AstraZeneca phase 3 clinical trial in lung cancer (LAURA). The findings demonstrate that Personalis' highly
10-16 21:08
仿冒名牌售“尾货”，网店店主获刑
转自：扬子晚报 有些网店店主会打出“工厂尾货”等诱人标语，低价“甩卖”所谓大牌服饰，事实上只是打着“尾货”的幌子，将“尾货”与假货掺着卖，行假冒伪劣之实。无锡...
10-11 21:16
Is Laureate Education Inc Gaining or Losing Market Support?
Laureate Education Inc's (NYSE:LAUR) short interest as a percent of float has r...
10-09 23:02
